Evaluation of Nutrients Intake for a Group of Jordanian Older Adults with Sarcopenia Syndrome in Amman: An Explorative and Pilot Study

Table 16

Mean intake of minerals for the sarcopenic patients compared to their recommendations.

Minerals	Intake mean ± SD	RCMD mean ± SD	value
Calcium (mg)	662.1 ± 268.1	1168.0 ± 74.8	≤0.001
Chromium (mcg)	2.04 ± 1.4	25.2 ± 4.9	≤0.001
Copper (mg)	0.63 ± 0.39	0.90 ± 0.0	0.003
Fluoride (mg)	0.37 ± 0.43	3.5 ± 0.5	≤0.001
Iodine (mcg)	90.2 ± 34.2	150 ± 0.0	≤0.001
Iron (mg)	9.2 ± 3.8	8.8 ± 2.8	0.613
Magnesium (mg)	165.8 ± 82.1	376.6 ± 51.4	≤0.001
Manganese (mg)	1.7 ± 1.1	2.0 ± 0.3	0.176
Molybdenum (mcg)	23.6 ± 34.1	45.0 ± 0.0	0.004
Phosphorus (mg)	712.2 ± 214.4	700 ± 0.0	0.778
Potassium (mg)	1476.9 ± 526.8	4700 ± 0.0	≤0.001
Selenium (mcg)	50.9 ± 29.0	55 ± 0.0	0.493
Sodium (mg)	1962.3 ± 3553.6	2300 ± 0.0	0.639
Zinc (mg)	6.19 ± 2.5	9.44 ± 1.5	≤0.001

is set as significant, (mcg): microgram, (mg): milligram, and SD: standard deviation.